🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Young Adult

Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients NCT07313592n/a1 site📍 St Louis Washington University School of Medicine Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia NCT04209244NA4 sites📍 Aalborg📍 Aarhus📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Eskimo-3 Pure Fish Oil, Rapeseed Oil Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis NCT07316452n/a1 site📍 Beijing Fu Wai Hospital, Beijing, China Comparing Vascular Responses to Resistance Exercise with and Without Blood Flow Restriction in Young and Older Adults NCT06596304NA2 sites📍 Almada📍 Almada Egas Moniz - Cooperativa de Ensino Superior, CRL · Tests: Low intensity-resistance training with lower limb blood flow restriction, High Intensity Resistance Training A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults NCT06508450NA1 site📍 The Bronx New York University · Tests: Just Do You, Component A, Component B, Component C Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability NCT07302048NA1 site📍 Brest University Hospital, Brest · Tests: MoDIDol intervention A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit NCT07173205NA2 sites📍 Greenville📍 Winston-Salem East Carolina University · Tests: AYA Survivors Coping and Emotional Needs Toolkit (ASCENT) Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors NCT07174661NA1 site📍 Scottsdale Mayo Clinic · Tests: Advance Care Planning, Educational Intervention, Electronic Health Record Review, Survey Administration Systemic Evaluation of the Etiologies of Young Adults With Non-traumatic Out-of-hospital Cardiac Arrest NCT06122337n/a1 site📍 Taipei National Taiwan University Hospital EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection NCT03266653Phase 28 sites📍 Los Angeles📍 San Francisco📍 Baltimore New York Medical College · Tests: cytotoxic t-lymphocytes A Comparison of Fisetin Kinetics in Young and Old Adults NCT06796374NA1 site📍 Greifswald University Medicine Greifswald · Tests: Fisetin - Fasted condition, Fisetin - Fed condition CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults NCT06305910Phase 11 site📍 Minneapolis OX2 Therapeutics · Tests: Treatment with CD200AR-L Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia NCT03932903NA1 site📍 Chicago Northwestern University · Tests: ADAPTS (ADherence Assessments and Personalized Timely Support). SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD) NCT05182697NA1 site📍 Beersheba Neurothera Labs Inc. · Tests: SCI-210, Oral CBD oil Zinc and Iron Absorption From Common Beans in Young Adult Women NCT06327529NA1 site📍 Davis University of California, Davis · Tests: SER 118, LMP 1001, LPA 586, KAT B1 Gummy Smile and Altered Passive Eruption Prevalence NCT07548398n/a1 site📍 Roma University of Roma La Sapienza · Tests: Clinical assessment Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention NCT07663448NA1 site📍 Providence Brown University · Tests: mHealth Intervention Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites📍 Washington D.C.📍 Baltimore📍 Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Consolidative radiation therapy (cRT) Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults NCT05465174Phase 220 sites📍 Birmingham📍 San Diego📍 San Francisco Sabine Mueller, MD, PhD · Tests: Tovorafenib E-CANE: a National Program of Remote Health Education Workshops NCT06748820n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Remote Therapeutic Patient Education (e-TPE) THE GUIDE: Transforming Health for Young Adults Using Interventions to Drive Engagement NCT06177600NA1 site📍 Boston Boston Children's Hospital · Tests: Interactive educational digital platform for transgender and gender-diverse (TGD) young adults and caregivers A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma NCT05533775Phase 1, Phase 230 sites📍 Birmingham📍 Oakland📍 Oakland Hoffmann-La Roche · Tests: Obinutuzumab, Glofitamab, Rituximab, Ifosfamide, Carboplatin A Study of Questionnaires in Adolescents and Young Adults With Cancer NCT07212166n/a7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Patient-Reported Outcome Surveys, Spanish version of PRO-AYA and the cognitive interview Prevention of Mental Disorders Through Self-efficacy Interventions NCT06738953NA1 site📍 Potsdam Health and Medical University Potsdam · Tests: Cognitive-Behavioral Intervention to increase Self Efficacy, Placebo: Weekly Recap and Group Discussion on Psychologica… DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Alectinib Social Facilitation of Alcohol Effects and Alcohol Misuse in Young Adults NCT06627803NA1 site📍 Los Angeles University of Southern California · Tests: Alcohol (Oral) Quality of Life in Pediatric Participants With HHT NCT07474428n/a1 site📍 Cincinnati Ashley Nelson DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition NCT05770102Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Atezolizumab Magnetic Resonance Imaging Study on Young and Middle-aged Patients With Cervical Spondylotic Pain NCT06217029n/a1 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: physiotherapy and maxillary traction
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy